Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sjögren syndrome.

K F Tabbara1, C L Vera-Cristo

  • 1Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. k.tabbara@nesma.net.sa

Current Opinion in Ophthalmology
|January 6, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of acute bacterial conjunctivitis with topical lomefloxacin 0.3% compared to topical ofloxacin 0.3.

European journal of ophthalmology·2017
Same author

Decrease in tear bioavailability of ciprofloxacin in eyes with carbon containing eyeliners.

Saudi medical journal·2016
Same author

Toxoplasmosis in Saudi Arabia.

Saudi medical journal·2016
Same author

Uveitis survey in children.

The British journal of ophthalmology·2008
Same author

Vogt-Koyanagi-Harada associated with diabetes mellitus and celiac disease in a 3-year-old girl.

European journal of ophthalmology·2006
Same author

Effect of cold BSS vs naphazoline 0.025% on ocular surface temperature.

Eye (London, England)·2005
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Sjögren syndrome is an autoimmune disease causing dry eyes and dry mouth due to gland damage. Research aims to understand immune dysregulation for better diagnosis and treatment of this chronic condition.

Area of Science:

  • Immunology
  • Rheumatology
  • Ophthalmology
  • Otolaryngology

Background:

  • Sjögren syndrome is a chronic autoimmune disorder.
  • It involves widespread glandular destruction, primarily affecting lacrimal and salivary glands.
  • Key symptoms include keratoconjunctivitis sicca (dry eyes) and xerostomia (dry mouth).

Purpose of the Study:

  • To elucidate the immune mechanisms underlying Sjögren syndrome.
  • To identify factors contributing to autoimmune dysregulation and glandular damage.
  • To explore potential improvements in diagnostic and therapeutic strategies.

Main Methods:

  • The study reviews the pathophysiology of Sjögren syndrome.
  • It focuses on the role of activated lymphocytes in targeting lacrimal and salivary glands.

Related Experiment Videos

  • Analysis of immune cell homing and tissue destruction mechanisms.

    • Main Results:

    • Autoimmune dysregulation leads to the destruction of acinar cells and ductal epithelia.
    • Activated lymphocytes selectively infiltrate lacrimal and salivary glands, causing damage.
    • Primary Sjögren syndrome presents with dry eyes and mouth; secondary Sjögren syndrome includes co-occurring autoimmune diseases like rheumatoid arthritis.

    Conclusions:

    • Understanding the immune dysregulation in Sjögren syndrome is crucial for advancing patient care.
    • Current treatments focus on symptom relief, secretion enhancement, and ocular surface repair.
    • Further research into immune factors may lead to more effective diagnostic and therapeutic interventions.